Related Experiment Video
Updated: Feb 17, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Management of antiplatelet therapy in patients undergoing neuroendovascular procedures
Keri S Kim1, Justin F Fraser2, Stephen Grupke3
11Department of Pharmacy Practice, University of Illinois Medical Center at Chicago, Illinois.
Insights
Neuroendovascular procedures require antiplatelet therapy to prevent clots. This review examines aspirin and clopidogrel use, guiding clinicians on managing variable patient responses to these crucial medications.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Neuroendovascular techniques are standard for cerebrovascular conditions.
- Devices like stents and coils necessitate antiplatelet therapy.
- Variable patient responses to aspirin and clopidogrel pose clinical challenges.
Purpose of the Study:
- To review literature on antiplatelet use in neuroendovascular procedures.
- To provide recommendations for managing variable antiplatelet responses.
- To focus on clopidogrel's pharmacodynamic variability.
Main Methods:
- Literature review of antiplatelet therapy in neuroendovascular interventions.
- Analysis of pharmacodynamic responses to aspirin and clopidogrel.
- Synthesis of clinical recommendations based on existing evidence.
Main Results:
- Antiplatelet therapy is essential but exhibits significant inter-individual variability.
- Clopidogrel response variability complicates treatment optimization.
- Current literature highlights the need for personalized antiplatelet strategies.
Conclusions:
- Clinicians must address variable antiplatelet responses in neuroendovascular patients.
- Personalized antiplatelet selection, especially for clopidogrel, is critical.
- Further research may refine antiplatelet management protocols for neuroendovascular care.
Abstract:
Neuroendovascular techniques for treating cerebral aneurysms and other cerebrovascular pathology are increasingly becoming the standard of care. Intraluminal stents, aneurysm coils, and other flow diversion devices typically require concomitant antiplatelet therapy to reduce thromboembolic complications. The variability inherent with the pharmacodynamic response to common antiplatelet agents such as aspirin and clopidogrel complicates optimal selection of antiplatelet agents by clinicians. This review serves to discuss the literature related to antiplatelet use in neuroendovascular procedures and provides recommendations for clinicians on how to approach patients with variable response to antiplatelet agents, particularly clopidogrel.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Aneurysm IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Angina IV: Management

